Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on DANS. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN108424937A reveals a novel enzymatic route for Danshensu. Discover cost-effective, scalable production methods for high-purity pharmaceutical intermediates supply.
Efficient Pd-catalyzed route for N-alkyl tetrahydrocarbazolone derivatives. High-yield Ondansetron intermediate synthesis with scalable supply chain benefits.
Patent CN118460491A reveals multi-enzyme cascade for D-Salvianic Acid. High purity, scalable process for pharmaceutical intermediates supply chain optimization.
Patent CN102875426A details a high-purity dansyl acid preparation method offering significant cost reduction and supply chain reliability for fluorescence applications.
Novel synthesis route for Ondansetron intermediate offers high purity and yield, reducing costs and supply chain risks for pharmaceutical manufacturers globally.
Patent CN106432199A details ultrasound resolution for ondansetron. Offers high purity and scalable manufacturing for reliable pharmaceutical intermediates supplier partnerships.
Patent CN100554403C reveals Microbacterium oxydans for high-purity chiral alcohol. Offers cost reduction and supply chain reliability for pharma intermediates.
Patent CN115677559A reveals a one-step microwave synthesis for tetrahydrocarbazolone, offering significant cost reduction and high purity for pharmaceutical supply chains.
Patent CN115677559A reveals a microwave-assisted one-step synthesis for high-purity ondansetron intermediates, offering significant cost reduction and supply chain reliability for pharmaceutical manufacturers.
Patent CN102382780A reveals a novel Microbacterium oxydans strain for high-purity chiral alcohol production, offering significant cost reduction and supply chain stability for global API manufacturers.
Advanced process for high-purity ondansetron synthesis reducing exo-methylene impurities. Cost-effective manufacturing solution for pharmaceutical supply chains.
Patent CN101993398B details a green catalytic hydrogenation method for 1,8-diamino-3,6-naphthalene disulfonic acid, offering high purity and eliminating iron sludge waste for reliable supply.
Patent CN106432199B reveals ultrasonic resolution for high-purity Ondansetron. Discover cost-effective manufacturing and supply chain advantages for pharmaceutical intermediates.
Patent CN103288630A details a novel synthesis of Sodium Danshensu from L-Tyrosine. This report analyzes the DKR strategy for cost-effective, high-purity API intermediate manufacturing.
Novel synthesis of Danshensu Isopropyl Ester via Darzens epoxidation ensures high purity and yield. Reliable supply chain partner for cardiovascular drug intermediates.
Replace zinc amalgam with 55% yield, 98% purity DL-Danshensu isopropyl ester synthesis. Eliminate environmental hazards and scale efficiently for cardiovascular drug development.